lobbying_activities: 3004288

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3004288	6b9efc91-f849-49d2-a635-2870de794827	Q2	TIBER CREEK GROUP	20744	JAZZ PHARMACEUTICALS	2023	second_quarter	MED	Issues related to cannabis research; issues related to the FDA; issues related to Cannabis research at Health and Human Services.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2023-07-14T14:54:22-04:00